2013
DOI: 10.1016/j.phymed.2012.12.012
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4′-tri-O-acetylresveratrol in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
62
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(70 citation statements)
references
References 14 publications
5
62
3
Order By: Relevance
“…Future investigations may address issues of optimization of oral bioavailability by considering alternative formulations (Amri et al, 2012), the use of resveratrol derivatives with higher oral availability, such as pterostilbene (e.g. Yeo et al, 2013), and since only relatively little resveratrol appears to find its way to the brain (Liang et al, 2013;Sale et al, 2004), the role of the parent compound relative to its metabolites, also known to be active (cf. Amri et al, 2012 In addition to the pharmacological normalization of the peripubertal stress-induced social deficit, the present study identified alterations in certain prefrontal cortex subregions following resveratrol treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Future investigations may address issues of optimization of oral bioavailability by considering alternative formulations (Amri et al, 2012), the use of resveratrol derivatives with higher oral availability, such as pterostilbene (e.g. Yeo et al, 2013), and since only relatively little resveratrol appears to find its way to the brain (Liang et al, 2013;Sale et al, 2004), the role of the parent compound relative to its metabolites, also known to be active (cf. Amri et al, 2012 In addition to the pharmacological normalization of the peripubertal stress-induced social deficit, the present study identified alterations in certain prefrontal cortex subregions following resveratrol treatment.…”
Section: Discussionmentioning
confidence: 99%
“…It has been documented that the high rate of the first-pass metabolism of drug, variable rate of gastric emptying and motility of the gastrointestinal tract may result in low bioavailability of the drug. The variation in degrees of drug response to the absorption site also influences the bioavailability (Liang et al 2013). For the oral route of administration, metabolism in the intestinal membrane and the liver is of major concern as it can reduce the systemic bioavailability of the drug (Kushwaha et al 2014).…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that approximately 30-40% of the new drug candidates failed during drug development process due to their poor pharmacokinetic properties (Grimaldi et al 1990;Liang et al 2013). Thus, animal models play a crucial role in understanding the pharmacokinetic properties of novel drugs (Kandhare et al 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Subsequent clinical trials are currently investigating this dose limit [307,310]. Resveratrol's poor bioavailability is a significant issue with regard to extrapolating its effects to humans, and various approaches have been created to enhance its bioavailability [311], including consuming it with various foods [312], using it in combination with an additional phytochemical piperine [313], and using a prodrug approach [314], micronized powders [315,316], or nanotechnological formulations [317][318][319].…”
Section: Clinical Trials With Resveratrolmentioning
confidence: 99%